Diabeto-Cardiology

Section 1 Diabetes Mellitus
1. Definition and Epidemiology of Type 2 Diabetes Mellitus
2. Insulin Resistance: Pathophysiology, Molecular Mechanisms, Genetic Insights
3. Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus
4. Pharmacological and Surgical Interventions That Prevent or Remit Type 2 Diabetes?
5. Type 1 Diabetes: Pathophysiology and Treatment Considerations for Cardiovascular Risk and Disease

Section 2 Cardiovascular Complications of Type 2 Diabetes
6. Atherosclerosis in Patients with Type 2 Diabetes: Epidemiology
7. Pathology and Vascular Biology of Atherosclerosis in Patients with Type 2 Diabetes: Inflammation, Dyslipidemia, Hypercoagulability, Endothelial Dysfunction, and Inflammation
8. Risk Stratification Among Patients with Type 2 Diabetes with or at Risk for Atherosclerotic Cardiovascular Disease
9. Epidemiology and Pathophysiology of Heart Failure with Preserved and with Reduced Ejection Fraction in Patients with Type 2 Diabetes

Section 3 Effects of Antihyperglycemic Therapies for Type 2 Diabetes on Cardiovascular and Kidney Outcomes
10. Effect of Acute and Chronic Glucose Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
11. Regulatory Approach to Medications for Type 2 Diabetes: Past, Present and Future
12. Cardiovascular and Kidney Effects of Sodium Glucose Co-transporter Inhibitors
13. Cardiovascular and Kidney Effects of Glucagon-like Peptide 1 Receptor Agonists
14. Antihyperglycemic Medications with Proven Cardiovascular Safety
15. Prevention of Heart Failure in Patients with Type 2 Diabetes
16. Treatment of Patients with Reduced and with Preserved Ejection Fraction Heart Failure in Patients with Type 2 Diabetes

Section 4 Management of Coronary Heart Disease Risk, Chronic and Acute Coronary Syndromes in Patients with Type 2 Diabetes
17. Effect of Lifestyle Interventions on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
18. Effect of Blood Pressure Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
19. Effect of Lipid Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
20. Effect of Antiplatelet and Anticoagulant Therapies on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
21. Therapeutic Implications of Type 2 Diabetes for Patients Undergoing Percutaneous or Surgical Coronary Revascularization
22. Epidemiology of Acute Coronary Syndromes in Patients with Type 2 Diabetes
23. Antiplatelet and Anticoagulant Therapy in Patients with Type 2 Diabetes with Acute Coronary Syndromes and/or Percutaneous Coronary Intervention

Section 5 Other Cardiovascular Considerations Associated with Type 2 Diabetes
24. Peripheral Artery Disease in Patients with Type 2 Diabetes
25. Cerebrovascular Disease in Patients with Type 2 Diabetes
26. Atrial Fibrillation in Patients with Type 2 Diabetes
27. Chronic Kidney Disease: Implications for Cardiovascular Risk and Management in Patients with Type 2 Diabetes
28. Disparities in Type 2 Diabetes Risk, Cardiovascular Consequences, and Care: Women, Race/Ethnic Minorities, and the Elderly
29. The Quality Chasm - Type 2 Diabetes

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Diabetes
• Medicina cardiovascular

Braunwald; Darren K. McGuire; Nikolaus Marx; Diabeto-Cardiology; diabetocardiology; diabetes and cardiology